Results 1 to 10 of about 478,988 (359)

Primary hepatoid adenocarcinoma of lung: A rare malignancy mimicking tuberculosis. [PDF]

Lung India, 2023
Singh R, Aggarwal S, Verma A, Sakhuja P, Nandi S, Garg K.   +5 more
europepmc   +2 more sources

ATF1 promotes the malignancy of lung adenocarcinoma cells by transcriptionally regulating ZNF143 expression

Acta Biochimica et Biophysica Sinica, 2023
The clinical oncogenic functions and mechanisms of activating transcription factor 1 (ATF1) in the progression of lung adenocarcinoma have not been completely elucidated.
Mei Jinhong, Liu Yu, Sheng Yiyun, Liu Ying, Chen Limin, Wang Hailong, Cheng Minzhang, Zhai Zhenyu, Xu Linlin   +8 more
doaj   +1 more source

Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China

Frontiers in Oncology, 2022
BackgroundThe main aim of the study was to determine the risk factors of lung adenocarcinoma and to analyze the variations in the incidence of lung adenocarcinoma according to time, sex, and smoking status in North China.MethodsPatients with lung cancer ...
Daojuan Li, Jin Shi, Xiaoping Dong, Di Liang, Jing Jin, Yutong He   +5 more
doaj   +1 more source

Expression of MAD2L1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment

Zhongliu Fangzhi Yanjiu, 2022
Objective To investigate the expression of MAD2L1 in lung adenocarcinoma and its effect on the prognosis and immune microenvironment of patients. Methods The difference of MAD2L1 expression in lung adenocarcinoma tissue and normal lung tissue was ...
LIU Yingbo, LIU Xiaohong, RU Meihua, LI Jianqiang   +3 more
doaj   +1 more source

High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma

Thoracic Cancer, 2022
Background The purpose of this study was to explore the reason for guanine nucleotide binding‐protein gamma subunit‐4 (GNG4) overexpression and the relationship between GNG4 overexpression and the poor prognosis of lung adenocarcinoma (LUAD) patients ...
Bodong Zhou, Wenbo Zhu, Shuai Yuan, Yifei Wang, Qing Zhang, Hong Zheng, Lei Zhu, Jie Xu   +7 more
doaj   +1 more source

UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma

World Journal of Surgical Oncology, 2022
Background Lung adenocarcinoma is the leading cause of cancer death worldwide. Recently, ubiquitin C-terminal hydrolase L1 (UCHL1) has been demonstrated to be highly expressed in many tumors and plays the role of an oncogene.
Jianbo Yao, Abdusemer Reyimu, Ao Sun, Zaxi Duoji, Wubi Zhou, Song Liang, Suxia Hu, Xiang Wang, Jingjing Dai, Xiaoguang Xu   +9 more
doaj   +1 more source

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma

Translational Oncology, 2022
Objectives: ARNTL2, as a circadian transcription factor, has been recently proposed to play an important role in a variety of tumors. however, the role of ARNTL2 in lung carcinogenesis and progression remains unclear.
Huan Zhang, Guangyao Shan, Xing Jin, Xiangyang Yu, GuoShu Bi, Mingxiang Feng, Hao Wang, Miao Lin, Cheng Zhan, Qun Wang, Ming Li   +10 more
doaj   +1 more source

Veillonella parvula promotes the proliferation of lung adenocarcinoma through the nucleotide oligomerization domain 2/cellular communication network factor 4/nuclear factor kappa B pathway

Discover Oncology, 2023
Enrichment of Veillonella parvula in the lung microbiota is strongly associated with non-small cell lung cancer (NSCLC) and induces the progression of lung adenocarcinoma in vivo, but its actual role and mechanism remain unexplored.
Wen Zeng, Yuhuan Wang, Zhe Wang, Mengge Yu, Kang Liu, Chengzhu Zhao, Yiyun Pan, Shudong Ma   +7 more
doaj   +1 more source

Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells [PDF]

Zhongguo aizheng zazhi, 2022
Background and purpose: Chromobox 3 (CBX3), an important component of chromatin, is involved in the development and progression of various cancers. However, the expression and role of CBX3 in lung adenocarcinoma are still unclear.
HOU Qinghua, ZHONG Yanfeng, LIU Linzhuang, WU Liusheng, LIU Jixian
doaj   +1 more source

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. [PDF]

, 2009
To address the biological heterogeneity of lung cancer, we studied 199 lung adenocarcinomas by integrating genome-wide data on copy number alterations and gene expression with full annotation for major known somatic mutations in this cancer.
Brennan, C, Broderick, S, Chitale, D, Gerald, W, Golas, B, Gong, Y, Ladanyi, M, Major, J, Motoi, N, Pao, W, Reinersman, J, Rusch, V, Sander, C, Seshan, V, Somwar, R, Szoke, J, Taylor, Barry, Wang, L, Zakowski, M   +18 more
core   +5 more sources